July 03, 2017

Second-quarter deals show a sector set on pause

Uncertainties around US healthcare and tax reforms is being blamed for the drop in dealmaking.

April 14, 2017

Upcoming events – Neurotrope aims for Alzheimer’s while brigatinib comes late to the Alk party

January 09, 2017

Takeda pays 2012 price for 2017-model Ariad

January 06, 2017

Select small caps stand out amid wider 2016 stock market declines

December 08, 2016

Ash winners and losers – Bluebird and Juno set the pulses racing

October 07, 2016

Lively M&A scene keeps biotech shares buoyant in Q3

May 10, 2016

Incyte’s European invasion

November 20, 2015

Interview – Bellicum takes on the suicide switch wannabes

September 01, 2015

The defensive anti-chain engulfs Ariad